Immunic, Inc. Hosts RMS R&D Day Webinar Sept 9, 2026

What Happened
Immunic, Inc. (IMUX) announced in a Form 8‑K (Item 7.01) that it will host a Relapsing Multiple Sclerosis (RMS) Research & Development Day webinar on Wednesday, September 9, 2026, from 11:00 a.m. to 12:30 p.m. ET via video conference. The company disclosed it intends to use a presentation during the event; that presentation is attached to the filing as Exhibit 99.1 and is incorporated by reference.

Key Details

• Filed on Form 8‑K under Item 7.01 (Regulation FD disclosure).
• Event: RMS R&D Day webinar on Sept 9, 2026, 11:00 a.m.–12:30 p.m. ET (video conference).
• Presentation used at the event is included in the filing as Exhibit 99.1 (dated Sept 9, 2026).

Why It Matters
This is a company-run research and development update focused on Immunic’s RMS program; the presentation will provide direct, company-sanctioned information about its pipeline and R&D plans. Because the disclosure was made under Regulation FD and attached to the 8‑K, material details presented at the webinar will be broadly available to all investors at the same time, which can help ensure a level playing field for assessing the company’s clinical progress and strategy.